Evidence map›Paper›PMID 21709240›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Overlapping activation-induced cytidine deaminase hotspot motifs in Ig class-switch recombination.

Li Han, Shahnaz Masani, Kefei Yu

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The mechanisms of human lymphoid chromosomal translocations and their medical relevance.Critical reviews in biochemistry and molecular biology · 2022
    Article
  12. Review
  13. Article
  14. The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Li HanDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA.
Shahnaz Masani
Kefei Yu

Funding

Targeted DNA cleavage at switch regions in immunoglobulin class switch recombinatR01AI081817 · NIAID · MICHIGAN STATE UNIVERSITY · PI YU, KEFEI · 2009 to 2013
$1.5M
NIAID NIH HHS R01 AI081817
6 · The paper itself

Abstract

Ig class-switch recombination (CSR) is directed by the long and repetitive switch regions and requires activation-induced cytidine deaminase (AID). One of the conserved switch-region sequence motifs (AGCT) is a preferred site for AID-mediated DNA-cytosine deamination. By using somatic gene targeting and recombinase-mediated cassette exchange, we established a cell line-based CSR assay that allows manipulation of switch sequences at the endogenous locus. We show that AGCT is only one of a family of four WGCW motifs in the switch region that can facilitate CSR. We go on to show that it is the overlap of AID hotspots at WGCW sites on the top and bottom strands that is critical. This finding leads to a much clearer model for the difference between CSR and somatic hypermutation.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsBase SequenceBinding SitesB-LymphocytesCell LineCytidine DeaminaseDNAImmunoglobulin Class SwitchingMiceMolecular Sequence DataMutagenesis, Site-DirectedMutationRecombination, GeneticAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDNA

Identifiers

PMID21709240
PMCPMC3136278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.